Concepedia

Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

Ignace Vergote, Neil J. Finkler, James B. Hall, O.O. Melnyk, Robert P. Edwards, Marsha Jones, James Keck, Lisa Meng, Gail L. Brown, Elaine M. Rankin,

International Journal of Gynecological Cancer · 2010 · 62 citations · 8 references

DOI

Concepts

References

8

Cancer Statistics, 2009

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text

, , +16

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

David G. Mutch, Mauro Orlando, T. Goss et al. · Journal of Clinical Oncology · 2007 · 441 citations · Full text

, , +15

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer

Alan N. Gordon, Margaret Tonda, Steven Sun et al. · Gynecologic Oncology · 2004 · 431 citations

, , +17

Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

Kenneth H. Cowan, Gerald Batist, Anil Tulpule et al. · Proceedings of the National Academy of Sciences · 1986 · 297 citations · Full text

, , +14

Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

Beverly A. Teicher, Sylvia A. Holden, Michael J. Kelley et al. · PubMed · 1987 · 291 citations

, , +13